Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole
Clinical trial NCT02234570 · COMPLETED
Trial details
- NCT number
- NCT02234570
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-17
- Primary completion
- 2015-11-24
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.